Genetic variation in CXCL12 and risk of cervical carcinoma: A population-based case-control study

International Journal of Immunogenetics

Volumn 36, Issue 6, 2009, Pages 367-375

  Maley, S N ^a,b   Schwartz, S M ^a,b   Johnson, L G ^b   Malkki, M ^b   Du, Q ^b   Daling, J R ^a,b   Li, S S ^b   Zhao, L P ^a,b   Petersdorf, E W ^b   Madeleine, M M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; ADOLESCENT; ALLELE; CANCER INVASION; CARCINOMA; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; UTERINE CERVIX TUMOR;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; ALLELES; CARCINOMA; CASE-CONTROL STUDIES; CHEMOKINE CXCL12; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VARIATION; HAPLOTYPES; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; POLYMORPHISM, SINGLE NUCLEOTIDE; UTERINE CERVICAL NEOPLASMS;

EID: 75549089242     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2009.00877.x     Document Type: Article

References (42)

1. Barrett, J.C., Fry, B., Mailer, J. & Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioin- formatics, 21, 263.
2. Bleul, C.C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Soroski, J. et al. (1996a) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature, 382, 829.
3. Bleul, C.C., Fuhlbrigge, R.C., Casasnovas, J.M., Aiuti, A. & Springer, T.A. (1996b) A highly efficacious lymphocyte chemo- attractant, stromal cell-derived factor 1 (SDF-1). Journal of Experimental Medicine, 184, 1101.
4. Bosch, F.X. & De Sanjose, S. (2003) Chapter 1: Human Papillomavirus and Cervical Cancer - Burden and Assessment of Causality. Journal of the National Cancer Institute, Monographs. 31 ,3.
5. Burger, J.A. & Kipps, T.J. (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood, 107, 1761.
6. Carlson, C.S., Eberle, M.A., Rieder, M.J., Yi, Q., Kruglyak, L. & Nickerson, D.A. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. American Journal of Human Genetics, 74, 106.
7. Carreon, J.D., Martin, M.P., Hildesheim, A., Gao, X., Schiffman, M., Herrero, R. et al. (2005) Human leukocyte antigen class I and II haplotypes and risk of cervical cancer. Tissue Antigens, 66, 321.
8. Carrington, M., Wang, S., Martin, M.P., Gao, X., Schiffman, M., Cheng, J. et al. (2005) Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin- like receptor and human leukocyte antigen loci. Journal of Experimental Medicine, 201, 1069.
9. Cordano, P., Lake, A., Shield, L., Taylor, G.M., Alexander, F.E., Taylor, P.R. et al. (2005) Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin's lymphoma. British Journal Haematology, 128, 493.
10. Daling, J.R., Madeleine, M.M., McKnight, B., Carter, J.J., Wipf, G.C., Ashley, R. et al. (1996) The relationship of human pap- illomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiology, Biomarkers and Prevention, 5,541.
11. Deshpande, A., Nolan, J.P., White, P.S., Valdez, Y.E., Hunt, W.C., Peyton, C.L. et al. (2005) TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. Journal of Infectious Diseases, 191, 969.
12. Diaz, G.A. (2005) CXCR4 mutations in WHIM syndrome: a misguided immune system? Immunological Reviews, 203,235-43.
13. Garcia-Moruja, C., Alonso-Lobo, J.M., Rueda, P., Torres, C., Gonzalez, N., Bermejo, M. et al. (2005) Functional characterization of SDF-1 proximal promoter. Journal ofMolecular Biology, 348, 43.
14. Gleichmann, M., Gillen, C., Czardybon, M., Bosse, F., Greiner-Petter, R., Auer, J. et al. (2000) Cloning and characterization of SDF-1gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system. European Journal of Neuroscience, 12, 1857.
15. Hankey, B.F., Ries, L.A. & Edwards, B.K. (1999) The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiology, Biomarkers and Prevention, 8, 1117.
16. Hendel, H., Henon, N., Lubuanec, H., Lachgar, A., Poncelet, H., Caillat-Zucman, S. et al. (1998) Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression. Journal of acquired immune deficiency syndromes and human retrovirology, 19, 381.
17. Hernandez, P.A., Gorlin, R.J., Lukens, J.N., Taniauchi, S., Bohinjec, J., Francois, F. et al. (2003) Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nature Genetics, 34, 70.
18. Hidalgo-Pascual, M., Galan, J.J., Chavez-Conde, M., Ramirez- Armengol., J.A., Moreno, C., Calvo, E. et al. (2007) Analysis of CXCL12 3'UTR G>A polymorphism in colorectal cancer. Oncology Reports, 18, 1583.
19. Hirata, H., Hinoda, Y., Kikuno, N., Kawamoto, K., Dahiya, A.V., Suehiro, Y. et al. (2007) CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clinical Cancer Research, 13, 5056.
20. Hussain, S.K., Madeleine, M.M., Johnson, L.G., Du, Q., Malkki, M., Wilkerson, H.W. et al. (2008) Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2. Cancer Epidemiology, Bio- markers and Prevention, 17, 1790.
21. IARC (2007). Human papillomaviruses.IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 90, 1-636.
22. Kimura, R., Nishioka, T., Soemantri, A. & Ishida, T. (2005) Allele-specific transcript quantification detects haplotypic variation in the levels of the SDF-1 transcripts. Human MolecularGenetics, 14, 1579.
23. Koizumi, K., Hojo, S., Akashi, T., Yasumoto, K. & Saiki, I. (2007) Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Science, 98, 1652.
24. Kucia, M., Jankowski, K., Reca, R., Wysoczynski, M., Bandura, L., Allendorf, D.J. et al. (2004) CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. Journal of Molecular Histology, 35, 233.
25. Li, S.S., Khalid, N., Carlson, C. & Zhao, L.P. (2003) Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms. Biostatistics, 4, 513
26. Libura, J., Drukala, J., Majka, M., Tomescu, O., Navenot, J.M., Kucia, M. et al. (2002) CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemo- taxis, and adhesion. Blood, 100, 2597
27. Madeleine, M.M., Johnson, L.G., Smith, A.G., Hansen, J.A., Nisperos, B.B., Li, S. et al. (2008) Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Research, 68, 3532.
28. Mehta, A.M., Jordanova, E.S., van Wezel, T., Uh, H.W., Corver, W.E., Kwappenberg, K.M. et al. (2007) Genetic variation of antigen processing machinery components and association with cervical carcinoma. Genes, Chromosomes and Cancer, 46, 577.
29. Modi, W.S., Scott, K., Goedert, J.J., Vlahov, D., Buchbinder, S., Detels, R. et al. (2005) Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study. Genes and Immunity, 6, 691.
30. Parkin, D.M., Bray, F., Ferlay, J. & Pisani, P. (2005) Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 55, 74.
31. Petersen, D.C., Glashoff, R.H., Shrestha, S., Bergeron, J., Laten, A., Gold, B. et al. (2005) Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population. Journal of Acquired Immune Deficiency Syndromes, 40, 521.
32. Razmkhah, M., Doroudchi, M., Ghayumi, S.M., Erfani, N., Ghaderi, A. et al. (2005a) Stromal cell-derived factor-1 (SDF- 1) gene and susceptibility of Iranian patients with lung cancer. Lung Cancer, 49, 311.
33. Razmkhah, M., Talei, A.R., Ghayumi, S.M., Erfani, N. & Ghaderi, A. (2005b) Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer Letters, 225, 261.
34. Reiche, E.M., Ehara Watanabe, M.A., Bonametti, A.M., Kaminami Morimoto, H., Akira Morimoto, A., Wiechmann, S.L. et al. (2006) The effect of stromal cell-derived factor 1 (SDF1/CXCL12) genetic polymorphism on HIV-1 disease progression. International Journal of Molecular Medicine, 18, 785.
35. Tseng, L.H., Lin, M.T., Shau, W.Y., Lin, W.C., Chang, F.Y., Chien, K.L. et al. (2006) Correlation of interleukin-10 gene haplotype with hepatocellular carcinoma in Taiwan. Tissue Antigens, 67, 127.
36. Vidal, F., Peraire, J., Domingo, P., Broch, M., Knobel, H., Pedrol, E. et al. (2005) Lack of association of SDF-1 3'A variant allele with long-term nonprogressive HIV-1 infection is extended beyond 16 years. Journal of Acquired Immune Deficiency Syndromes, 40, 276.
37. Walboomers, J.M., Jacobs, M.V., Manos, M.M., Bosch, F.X., Kummer, J.A., Shah, K.V. et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189, 12.
38. Winer, R.L., Lee, S.K., Hughes, J.P., Adam, D.E., Kiviat, N.B. & Koutsky, L.A. (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. American Journal of Epidemiology, 157, 218.
39. Yang, Y., Li, S.S., Chien, J., Andriesen, J. & Zhao, L.P. (2008) A systematic search for SNPs/haplotypes associated with disease phenotypes using a haplotype-based stepwise procedure. BMC Genet, 9, 90.
40. Yu, L., Cecil, J., Peng, S.B., Schrementi, J., Kovacevic, S., Paul, D. et al. (2006) Identification and expression of novel isoforms of human stromal cell-derived factor 1. Gene, 374, 174.
41. Zafiropoulos, A., Crikas, N. et al. (2004) Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. Journal of Medical Genetics, 41, e59.
42. Zhang, J.P., Lu, W.G., Passam, A.M. & Spandidos, D.A. (2007) Study on CXCR4/SDF-1alpha axis in lymph node metastasis of cervical squamous cell carcinoma. Int J Gynecol Cancer, 17, 478.